Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients

(1) Background: Therapeutic blocking of the interaction between programmed death-1 (PD-1) with its ligand PD-L1, an immune checkpoint, is a promising approach to restore the antitumor immune response. Improved clinical outcomes have been shown in different human cancers, including non-small cell lun...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Berghmans, Eline, Jacobs, Julie, Deben, Christophe, Hermans, Christophe, Broeckx, Glenn, Smits, Evelien, Maes, Evelyne, Raskin, Jo, Pauwels, Patrick, Baggerman, Geert
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225984/
https://ncbi.nlm.nih.gov/pubmed/32252405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040863
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki